The Sydney-based firm expects to see more international LPs in its third private equity vehicle, while it actively exits its portfolio.
2 min read · 19 September 2013
Investors highlighted lower management fees as a key incentive to invest in funds, while GPs note investor hesitation about the asset class in general.
2 min read · 19 September 2013
Yibing Wu, currently president of CITIC PE, will join Temasek as its head of China as incumbent Wei Ding takes an advisory role.
2 min read · 19 September 2013
The firms have acquired a US-based coffee chain with a network in Asia and aim to expand the business further across the region.
2 min read · 19 September 2013
The secondaries market globally is ramping up as large amounts of dry powder strain dealflow, according to an SEI survey.
2 min read · 19 September 2013
The firm and co-investor Plenty Gold have sold a partial shareholding in a Chinese pharmaceutical company as the sector drums up investor interest.
2 min read · 19 September 2013
The firms were cornerstone investors for the $203m listing of China-based food and drink company Tenwow, with the offering oversubscribed by retail investors.
2 min read · 19 September 2013
The firm has raised $50m from LPs, a large step down from its $430m predecessor vehicle, as it refocuses on the local market.
2 min read · 19 September 2013
InvAscent targets healthcare deals in India, and has former doctors as operating partners. Hari Buggana, managing director, says the sector is way underserved.
3 min read · 19 September 2013
The firm, which is predominantly focused on Thailand, has reached a final close having been oversubscribed.
2 min read · 19 September 2013
